Saturday, July 11, 2026

pharma · No medical condition. · Generalized Myasthenia Gravis

Anaxis Pharma

Lacuna Pharma Pty is a pharma organization headquartered in Colmenar Viejo, AU. Primary therapeutic focus areas include No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial

Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2017
Employees
7
Programs
642
Drugs
673
Patents
0
Clinical program

alpha 1H, Placebo product for Alpha1H

Phase 2 · small molecule · Non-muscle invasive bladder cancer awaiting transurethral surgery

alpha 1H, Placebo product for Alpha1H for Non-muscle invasive bladder cancer awaiting transurethral surgery is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Lacuna Pharma Pty Ltd projects Phase 2 small molecule active

Internal code HP002-001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Lacuna Pharma Pty Ltd
Phase
Phase 2
Modality
small_molecule
Indication
Non-muscle invasive bladder cancer awaiting transurethral surgery
Status
active
Trials
1